CLONING AND FUNCTIONAL-CHARACTERIZATION THROUGH ANTISENSE MAPPING OF A KAPPA(3)-RELATED OPIOID RECEPTOR

Citation
Yx. Pan et al., CLONING AND FUNCTIONAL-CHARACTERIZATION THROUGH ANTISENSE MAPPING OF A KAPPA(3)-RELATED OPIOID RECEPTOR, Molecular pharmacology, 47(6), 1995, pp. 1180-1188
Citations number
44
Categorie Soggetti
Pharmacology & Pharmacy",Biology
Journal title
ISSN journal
0026895X
Volume
47
Issue
6
Year of publication
1995
Pages
1180 - 1188
Database
ISI
SICI code
0026-895X(1995)47:6<1180:CAFTAM>2.0.ZU;2-L
Abstract
We have identified a putative opioid receptor from mouse brain (KOR-3) , belonging to the G protein-coupled receptor family, that is distinct from the previously cloned mu, delta, and kappa(1) receptors. Assignm ent of the clone to the opioid receptor family derives from both struc tural and functional studies. Its predicted amino acid sequence is hig hly homologous to that of the other opioid receptors, particularly in many of the transmembrane regions, where long stretches are identical to mu, delta, and kappa(1) receptors. Both cyclazocine and nalorphine inhibit cAMP accumulation in COS-7 cells stably expressing the clone. Northern analysis shows that the mRNA is present in brain but not in a number of other organs. Southern analysis suggests a single gene enco ding the receptor. A highly selective monoclonal antibody directed aga inst the native kappa(3) receptor recognizes, in Western analysis, the clone expressed in COS-7 cells. The in vitro translation product is a lso labeled by the antibody. Additional clones reveal the presence of several introns, including one in the second extracellular loop and an other in the first transmembrane region. Antisense studies with an oli godeoxynucleotide directed against a region of the second extracellula r loop reveal a selective blockade of kappa(3) analgesia in vivo that is not observed with a mismatch oligodeoxynucleotide based upon the an tisense sequence. The mu, delta, and kappa(1) analgesia is unaffected by this antisense treatment. Antisense mapping of the clone downstream from the splice site in the first transmembrane region reveals that s ix different antisense oligodeoxynucleotides all block kappa(3) analge sia. In contrast, only one of an additional six different antisense ol igodeoxynucleotides directed at regions upstream from this splice site is effective. This strong demarcation between the two regions raises the possibility of splice variants of the receptor. An additional clon e reveals an insert in the 3' untranslated region. In conclusion, the antibody and antisense studies strongly associate KOR-3 with the kappa (3)-opioid receptor, although it is not clear whether it is the kappa( 3) receptor itself or a splice variant.